澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

global harvest pharmaceuticals pty ltd - metaraminol tartrate, quantity: 5.7 mg (equivalent: metaraminol, qty 3 mg) - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metaraminol tartrate, quantity: 9.49 mg (equivalent: metaraminol, qty 5 mg) - injection, solution - excipient ingredients: water for injections; sodium metabisulfite; sodium chloride - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - metaraminol tartrate, quantity: 18.976 mg (equivalent: metaraminol, qty 10 mg) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; water for injections - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - metaraminol tartrate, quantity: 9.5 mg - injection, solution - excipient ingredients: sodium metabisulfite; sodium hydroxide; water for injections; hydrochloric acid; sodium chloride - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

wockhardt bio pty ltd - metaraminol tartrate, quantity: 9.5 mg - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; sodium metabisulfite; hydrochloric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - eptifibatide - solution for injection - 2mg/1ml

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord healthcare ltd - eptifibatide - solution for injection - 2mg/1ml

亚美尼亚 - 英文 - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxo operations uk ltd. - eptifibatide - solution for infusion - 0,75mg/ml

亚美尼亚 - 英文 - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxo operations uk ltd. - eptifibatide - solution for injection - 2mg/ml

亚美尼亚 - 英文 - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

glaxo operations uk ltd. - eptifibatide - solution for injection - 2mg/ml